CATAFAST 50mg POWDER FOR SOLUTION / كاتافاست 50 مغ بودرة للحل

Catafast 50 mg

Powder for oral solution in sachets of 50 mg diclofenac potassium.

Indications:

Short-term treatment in the following acute conditions:

• Post-traumatic pain, inflammation and swelling, e.g. due to sprains,
• Post-operative pain, inflammation and swelling, e.g. following dental or orthopaedic surgery,
• Painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis, migraine attacks,
• Painful syndromes of the vertebral column, nonarticular rheumatism, as an adjuvant in severe painful inflammatory infections of the ear, nose or throat.

Dosage:

Dose to be individually adjusted, lowest effective dose to be given for the shortest duration.

Adults: 50 to 150 mg daily in divided doses. For dysmenorrhoea and migraine   

             attacks: up to 200 mg daily.

Adolescents aged 14 and over: 50 to 100 mg daily in divided doses up to

                                                      150mg daily.

Children and adolescents below 14 years of age: not recommended.

Contraindications:

Active gastric or intestinal ulcer, bleeding or perforation; known hypersensitivity to diclofenac or to any of the excipients, to aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs); Patients in whom attacks of asthma, urticaria, or acute rhinitis are precipitated by acetylsalicylic acid or other NSAIDs; last trimester of pregnancy; severe hepatic, renal or cardiac failure.

Adverse reactions:

Common undesirable effects are: Headache, dizziness, vertigo, nausea, vomiting, diarrhoea, dyspepsia, abdominal pain, flatulence, anorexia, transaminases increased, rash.